Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

PROTAC

Items 71-80 of 85

Page
per page
  1. PD0325901-O-C2-dioxolane
    BA6503 PD0325901-O-C2-dioxolane
    Summary: PD0325901-O-C2-dioxolane contains an inhibitor PD0325901 major fraction.
  2. CDK9-IN-10
    BA3838 CDK9-IN-10
    Summary: CDK9-IN-10 is a potent inhibitor.
  3. Quizartinib (AC220)
    A5793 Quizartinib (AC220)
    Target: FLT3
    Summary: FLT3 inhibitor,potent and selective
      ≥28.03 mg/mL
  4. Bromodomain Inhibitor, (+)-JQ1
    A1910 Bromodomain Inhibitor, (+)-JQ1
     66 Citation
    Target: Bromodomains
    Summary: BET bromodomain inhibitor
      ≥22.85 mg/mL
  5. PCI-32765 (Ibrutinib)
    A3001 PCI-32765 (Ibrutinib)
     7 Citation
    Summary: Bruton's tyrosine kinase (BTK) inhibitor
      ≥22.02 mg/mL
  6. SIAIS178
    BA8805 SIAIS178
    Summary: SIAIS178 is a class of effective, selective degradation agents.
  7. NV03
    BA4847 NV03
    Summary: NV03 is a potent, selective and interacting antagonist.
  8. Thalidomide-4-OH
    C6597 Thalidomide-4-OH
      ≥51.2 mg/mL
  9. SMER 3
    B5567 SMER 3
    Summary: yeast SCF family E3 ubiquitin ligase (SCFMet30) inhibitor
      Soluble in DMSO
  10. Lenalidomide hemihydrate
    B1188 Lenalidomide hemihydrate
    Summary: TNF-α secretion inhibitor
      insoluble in H2O; insoluble in EtOH; ≥30.1 mg/mL

Items 71-80 of 85

Page
per page